IL92120A - Cyclosporine ophthalmic preparations - Google Patents

Cyclosporine ophthalmic preparations

Info

Publication number
IL92120A
IL92120A IL9212089A IL9212089A IL92120A IL 92120 A IL92120 A IL 92120A IL 9212089 A IL9212089 A IL 9212089A IL 9212089 A IL9212089 A IL 9212089A IL 92120 A IL92120 A IL 92120A
Authority
IL
Israel
Prior art keywords
composition according
component
composition
present
cyclosporin
Prior art date
Application number
IL9212089A
Other languages
English (en)
Hebrew (he)
Other versions
IL92120A0 (en
Original Assignee
Sandoz A G Basle Switzerland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz A G Basle Switzerland filed Critical Sandoz A G Basle Switzerland
Publication of IL92120A0 publication Critical patent/IL92120A0/xx
Publication of IL92120A publication Critical patent/IL92120A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13Cyclosporins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
IL9212089A 1988-10-26 1989-10-25 Cyclosporine ophthalmic preparations IL92120A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26286688A 1988-10-26 1988-10-26

Publications (2)

Publication Number Publication Date
IL92120A0 IL92120A0 (en) 1990-07-12
IL92120A true IL92120A (en) 1994-02-27

Family

ID=22999400

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9212089A IL92120A (en) 1988-10-26 1989-10-25 Cyclosporine ophthalmic preparations

Country Status (24)

Country Link
JP (1) JPH02164830A (it)
KR (1) KR900005973A (it)
AU (1) AU626928B2 (it)
BE (1) BE1003578A4 (it)
CA (1) CA2001502A1 (it)
CH (1) CH679210A5 (it)
DE (1) DE3935517A1 (it)
DK (1) DK531289A (it)
ES (1) ES2020032A6 (it)
FI (1) FI895064A0 (it)
FR (1) FR2638089A1 (it)
GB (1) GB2224205B (it)
GR (1) GR1000611B (it)
HU (1) HU203046B (it)
IL (1) IL92120A (it)
IT (1) IT1237824B (it)
LU (1) LU87613A1 (it)
MY (1) MY106271A (it)
NL (1) NL8902657A (it)
NO (1) NO894266L (it)
NZ (1) NZ231131A (it)
PT (1) PT92120B (it)
SE (1) SE8903583L (it)
ZA (1) ZA898140B (it)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
CA2002147A1 (en) * 1988-11-07 1990-05-07 Shuichi Morikawa Production process for polyimide fibers
US5540931A (en) * 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
FR2670629B1 (fr) * 1990-12-17 1995-03-10 Moving Magnet Tech Actionneur electromagnetique monophase rotatif.
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
ZA927277B (en) * 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
SG45449A1 (en) 1992-05-13 1998-01-16 Sandoz Ltd Ophthalmic compositions
US5366739A (en) * 1992-08-06 1994-11-22 Deo Corporation Method of ophthalmic drug delivery
US5830508A (en) * 1992-08-06 1998-11-03 Deo Corporation Composition for treating dry eye
ES2168271T3 (es) 1992-09-25 2002-06-16 Novartis Ag Composiciones farmaceuticas que contienen ciclosporinas.
US5698533A (en) * 1994-07-26 1997-12-16 Kang; Meng-Che Ophthalmic pharmaceutical composition
PT789580E (pt) 1994-11-03 2002-09-30 Novartis Ag Formulacoes de ciclosporina para administracao oral com composicao simples e alta biodisponibilidade e processo para a sua producao
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5766629A (en) * 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
CZ295207B6 (cs) 1997-01-30 2005-06-15 Novartis Ag Tvrdá želatinová tobolka obsahující cyklosporin A
US6254860B1 (en) * 1999-04-13 2001-07-03 Allergan Sales, Inc. Ocular treatment using cyclosporin-A derivatives
US7557082B2 (en) * 2006-03-03 2009-07-07 Allergan, Inc. Treatment with cyclosporin A
US20100286121A1 (en) * 2007-11-05 2010-11-11 Rohrs Brian R Water-Immiscible Materials as Vehicles for Drug Delivery
KR101778316B1 (ko) * 2009-06-05 2017-09-13 알러간, 인코포레이티드 인공 눈물 및 치료학적 용도
AU2015353701B2 (en) 2014-11-25 2021-03-25 Allergan, Inc. Stabilized omega-3 ophthalmic compositions
EP4201398A1 (en) * 2021-12-24 2023-06-28 Isoxa S.r.l. Isocyclosporin a for topical treatment of ocular diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649047A (en) * 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
US4839342A (en) * 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin

Also Published As

Publication number Publication date
GR890100690A (en) 1990-11-29
CH679210A5 (it) 1992-01-15
SE8903583D0 (sv) 1989-10-26
AU626928B2 (en) 1992-08-13
KR900005973A (ko) 1990-05-07
NO894266L (no) 1990-04-27
MY106271A (en) 1995-04-29
LU87613A1 (fr) 1991-05-07
IT1237824B (it) 1993-06-18
GB8924040D0 (en) 1989-12-13
DK531289D0 (da) 1989-10-25
FR2638089A1 (fr) 1990-04-27
FI895064A0 (fi) 1989-10-25
HUT52394A (en) 1990-07-28
DE3935517A1 (de) 1990-05-03
PT92120A (pt) 1990-04-30
GR1000611B (el) 1992-08-31
NO894266D0 (no) 1989-10-26
GB2224205B (en) 1992-04-15
IT8948485A0 (it) 1989-10-26
HU895444D0 (en) 1990-01-28
CA2001502A1 (en) 1990-04-26
JPH02164830A (ja) 1990-06-25
DK531289A (da) 1990-04-27
NZ231131A (en) 1992-06-25
NL8902657A (nl) 1990-05-16
BE1003578A4 (fr) 1992-04-28
HU203046B (en) 1991-05-28
ES2020032A6 (es) 1991-07-16
PT92120B (pt) 1995-06-30
AU4371589A (en) 1990-05-03
GB2224205A (en) 1990-05-02
SE8903583L (sv) 1990-04-27
ZA898140B (en) 1991-06-26
IL92120A0 (en) 1990-07-12

Similar Documents

Publication Publication Date Title
AU626928B2 (en) Cyclosporin opthalmic compositions
US5951971A (en) Ophthalmic compositions
Constad et al. Use of an angiotensin converting enzyme inhibitor in ocular hypertension and primary open-angle glaucoma
US5294604A (en) Method of treating ocular diseases by periocular administration of cyclosporine A or G
US6579901B2 (en) Pharmaceutical compositions and methods for treating immune-response associated diseases of the surface and the anterior segment of the eye
Flach et al. The quantitative effect of 0.5% ketorolac tromethamine solution and 0.1% dexamethasone sodium phosphate solution on postsurgical blood-aqueous barrier
KR20070094600A (ko) 안질환 치료제
US11654140B2 (en) Treatment of ocular inflammatory diseases using laquinimod
JPH0216728B2 (it)
CZ423797A3 (cs) Topické přípravky s imunosupresivy
JPH0381220A (ja) 眼病用製薬組成物
van Sorge et al. Flurbiprofen, S (+), eyedrops: formulation, enantiomeric assay, shelflife and pharmacology
JP2022546980A (ja) ブドウ膜炎の治療のための眼科用組成物
RU2434633C2 (ru) Фармацевтические препаративные формы латрункулина
Grehn et al. Thymoxamine: a miotic for intraocular use
Francisco Solution on Postsurgical Blood-Aqueous Barrier

Legal Events

Date Code Title Description
RH Patent void